{"status": "Ok", "redirect_url": "https://bristolmyers2016ir.q4web.com/iframes/press-releases/press-release-details/2026/U-S--FDA-Grants-Accelerated-Approval-to-Bristol-Myers-Squibbs-First-CELMoD-Therapy-ZENBEXUS-in-Combination-with-Daratumumab-and-Hyaluronidase-fihj-and-Dexamethasone-ZDd-for-Patients-with-Multiple-Myeloma-as-Early-as-First-Relapse/default.aspx", "message": "News view counter 882519 successfully enlarged"}